Cyberknife stereotactic radiation therapy for stage I lung cancer and pulmonary metastases: evaluation of local control at 24 months.

Fiche publication

Date publication

août 2018

Journal

Journal of thoracic disease

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEIFFERT Didier

Tous les auteurs :
Khadige M, Salleron J, Marchesi V, Oldrini G, Peiffert D, Beckendorf V

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/30233872

Résumé

CyberKnife stereotactic radiotherapy allows for minimally invasive treatment with satisfactory results in patients with inoperable primary or metastatic lung cancer. The objective of this study was to identify factors influencing the probability of local control.